Vitamin D status in relation to Crohn's disease: Meta-analysis of observational studies

Nutrition

Volumn 32, Issue 5, 2016, Pages 505-514

  Sadeghian, Mehdi ^a,b   Saneei, Parvane ^a,b   Siassi, Fereydoun ^c   Esmaillzadeh, Ahmad ^a,b,c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crohn's disease; Deficiency; Disease activity; Meta analysis; Vitamin D status

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; 25 HYDROXYERGOCALCIFEROL;

CASE CONTROL STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ADULT; BLOOD; CHILD; EVIDENCE BASED MEDICINE; GLOBAL HEALTH; META ANALYSIS; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SUNLIGHT;

25-HYDROXYVITAMIN D 2; ADULT; CHILD; CROHN DISEASE; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HUMANS; NUTRITIONAL STATUS; OBSERVATIONAL STUDIES AS TOPIC; PREVALENCE; SEVERITY OF ILLNESS INDEX; SUNLIGHT; VITAMIN D DEFICIENCY;

EID: 84962532535     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.11.008     Document Type: Review

References (98)

1. "Crohn's Disease". National Digestive Diseases Information Clearinghouse. July 10, 2013. Available at: Retrieved 12 June 2014. http://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/crohns-disease/Pages/facts.aspx.
2. Sobczak M., Fabisiak A., Murawska N., Wesolowska E., Wierzbicka P., Wlazlowski M., et al. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases. Pharmacol Rep 2014, 66:766-775.
3. Taghavi S.A., Safarpour A.R., Hosseini S.V., Noroozi H., Safarpour M., Rahimikazerooni S. Epidemiology of inflammatory bowel diseases (IBD) in Iran: a review of 740 patients in Fars province, Southern Iran. Ann Colorectal Res 2013, 1:17-22.
4. Stefanelli T., Malesci A., Repici A., Vetrano S., Danese S. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets. Curr Drug Targets 2008, 9:413-418.
5. Ananthakrishnan A.N. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2013, 9:367-374.
6. Amre D.K., D'Souza S., Morgan K., Seidman G., Lambrette P., Grimard G., et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007, 102:2016-2025.
7. Riordan A.M., Ruxton C.H., Hunter J.O. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998, 52:229-238.
8. Ham M., Longhi M.S., Lahiff C., Cheifetz A., Robson S., Moss A.C. Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment. Inflamm Bowel Dis 2014, 20:856-860.
9. Calcium and vitamin D intakes influence the risk of bowel cancer in men. Nutr Rev 1985, 43:170-172.
10. Dumitrescu G., Mihai C., Dranga M., Prelipcean C.C. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World J Gastroenterol 2014, 20:2392-2396.
11. Levin A.D., Wadhera V., Leach S.T., Woodhead H.J., Lemberg D.A., Mendoza-Cruz A.C., et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci 2011, 56:830-836.
12. Harries A.D., Brown R., Heatley R.V., Williams L.A., Woodhead S., Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985, 26:1197-1203.
13. Tajika M., Matsuura A., Nakamura T., Suzuki T., Sawaki A., Kato T., et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 2004, 39:527-533.
14. El-Matary W., Sikora S., Spady D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 2011, 56:825-829.
15. Fu Y.T., Chatur N., Cheong-Lee C., Salh B. Hypovitaminosis D in adults with inflammatory bowel disease: potential role of ethnicity. Dig Dis Sci 2012, 57:2144-2148.
16. Ananthakrishnan A.N., Khalili H., Higuchi L.M., Bao Y., Korzenik J.R., Giovannucci E.L., et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012, 142:482-489.
17. Leslie W.D., Miller N., Rogala L., Bernstein C.N. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol 2008, 103:1451-1459.
18. Ananthakrishnan A.N., Cheng S., Cai T., Cagan A., Gainer V.S., Szolovits P., et al. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014, 12:821-827.
19. Ananthakrishnan A.N., Cagan A., Gainer V.S., Cai T., Cheng S.C., Savova G., et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis 2013, 19:1921-1927.
20. Trebble T.M., Wootton S.A., Stroud M.A., Mullee M.A., Calder P.C., Fine D.R., et al. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status. Aliment Pharmacol Ther 2004, 19:1063-1071.
21. Hilmi I., Sunderesvaran K., Ananda V., Sarji S.A., Arumugam K., Goh K.L. Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease. J Clin Endocrinol Metab 2013, 98:2415-2421.
22. Laakso S., Valta H., Verkasalo M., Toiviainen-Salo S., Makitie O. Compromised peak bone mass in patients with inflammatory bowel disease-a prospective study. J Pediatr 2014, 164:1436-1443.e1.
23. Goodhand J.R., Kamperidis N., Joshi N.M., Wahed M., Koodun Y., Cantor E.J., et al. The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent. Aliment Pharmacol Ther 2012, 35:929-940.
24. Schulte C., Dignass A.U., Mann K., Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 1998, 4:268-275.
25. van Langenberg D.R., Gatta P.D., Hill B., Zacharewicz E., Gibson P.R., Russell A.P. Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease. J Crohns Colitis 2013, 8:626-634.
26. Abraham B.P., Prasad P., Malaty H.M. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Dig Dis Sci 2014, 59:1878-1884.
27. Vogelsang H., Ferenci P., Woloszczuk W., Resch H., Herold C., Frotz S., et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 1989, 34:1094-1099.
28. Shirazi K.M., Somi M.H., Rezaeifar P., Fattahi I., Khoshbaten M., Ahmadzadeh M. Bone density and bone metabolism in patients with inflammatory bowel disease. Saudi J Gastroenterol 2012, 18:241-247.
29. Ulitsky A., Ananthakrishnan A.N., Naik A., Skaros S., Zadvornova Y., Binion D.G., et al. Vitamin D deficiency in patients with inflammatory bowel disease association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 2011, 35:308-316.
30. Wiese D., Lashner B., Seidner D. Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy. Nutr Clin Pract 2008, 23:551-556.
31. Nakajima S., Iijima H., Egawa S., Shinzaki S., Kondo J., Inoue T., et al. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease. Nutrition 2011, 27:1023-1028.
32. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: . http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
33. Chatu S., Chhaya V., Holmes R., Neild P., Kang J.Y., Pollok R.C., et al. Factors associated with vitamin D deficiency in a multicultural inflammatory bowel disease cohort. Frontline Gastroenterol 2012, 4:51-56.
34. Miznerova E., Hlavaty T., Koller T., Toth J., Holociova K., Huorka M., et al. The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease. Bratisl Lek Listy 2013, 114:439-445.
35. Prosnitz A.R., Leonard M.B., Shults J., Zemel B.S., Hollis B.W., Denson L.A., et al. Changes in vitamin D and parathyroid hormone metabolism in incident pediatric Crohn's disease. Inflamm Bowel Dis 2013, 19:45-53.
36. Garg M., Rosella O., Lubel J.S., Gibson P.R. Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2013, 19:2634-2643.
37. Abreu M.T., Kantorovich V., Vasiliauskas E.A., Gruntmanis U., Matuk R., Daigle K., et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 2004, 53:1129-1136.
38. Siffledeen J.S., Siminoski K., Steinhart H., Greenberg G., Fedorak R.N. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol 2003, 17:473-478.
39. Bours P.H., Wielders J.P., Vermeijden J.R., van de Wiel A. Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporos Int 2011, 22:2857-2867.
40. Haderslev K.V., Jeppesen P.B., Sorensen H.A., Mortensen P.B., Staun M. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut 2003, 52:653-658.
41. Hassan V., Hassan S., Seyed-Javad P., Ahmad K., Asieh H., Maryam S., et al. Association between serum 25 (OH) vitamin D concentrations and inflammatory bowel diseases (IBDs) activity. Med J Malaysia 2013, 68:34-38.
42. Sonnenberg A., Ehms H., Sonnenberg G.E., Strohmeyer G. 25-hydroxycholecalciferol serum levels in patients with Crohn's disease. Acta Hepatogastroenterol (Stuttg) 1977, 24:293-295.
43. Driscoll R.H., Meredith S.C., Sitrin M., Rosenberg I.H. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982, 83:1252-1258.
44. Westarp C.V., Thomson A., Overton T., Rogers R., Hodges P., Fornasier V., et al. Disorders of mineral and bone metabolism in patients with Crohn's disease. Can J Gastroenterol Hepatol 1987, 1:11-17.
45. Martin A., Walter F., Luisetto G., Mussolin L., Plebani M., Giacomin D., et al. Bone density and calcium metabolism in patients with long-standing, quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1994, 6.
46. Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 1996, 239:131-137.
47. Pollak R.D., Karmeli F., Eliakim R., Ackerman Z., Tabb K., Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998, 93:1483-1490.
48. Gokhale R., Favus M.J., Karrison T., Sutton M.M., Rich B., Kirschner B.S. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998, 114:902-911.
49. Ardizzone S., Bollani S., Bettica P., Bevilacqua M., Molteni P., Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000, 247:63-70.
50. Lamb E.J., Wong T., Smith D.J., Simpson D.E., Coakley A.J., Moniz C., et al. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2002, 16:1895-1902.
51. Duggan P., O'Brien M., Kiely M., McCarthy J., Shanahan F., Cashman K.D. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am J Gastroenterol 2004, 99:2178-2185.
52. McCarthy D., Duggan P., O'Brien M., Kiely M., McCarthy J., Shanahan F., et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 2005, 21:1073-1083.
53. Gilman J., Shanahan F., Cashman K.D. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2006, 23:1007-1016.
54. Joseph A.J., George B., Pulimood A.B., Seshadri M.S., Chacko A. 25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity. Indian J Med Res 2009, 130:133-137.
55. Kumari M., Khazai N.B., Ziegler T.R., Nanes M.S., Abrams S.A., Tangpricha V. Vitamin D-mediated calcium absorption in patients with clinically stable Crohn's disease: a pilot study. Mol Nutr Food Res 2010, 54:1085-1091.
56. Suibhne T.N., Cox G., Healy M., O'Morain C., O'Sullivan M. Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis 2012, 6:182-188.
57. Laakso S., Valta H., Verkasalo M., Toiviainen-Salo S., Viljakainen H., Makitie O. Impaired bone health in inflammatory bowel disease: a case-control study in 80 pediatric patients. Calcif Tissue Int 2012, 91:121-130.
58. Vazquez M.A., Lopez E., Montoya M.J., Giner M., Perez-Temprano R., Perez-Cano R. Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study. BMC Gastroenterol 2012, 12:47.
59. El-Hodhod M.A., Hamdy A.M., Abbas A.A., Moftah S.G., Ramadan A.A. Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease. BMC Gastroenterol 2012, 12:44.
60. Grunbaum A., Holcroft C., Heilpern D., Gladman S., Burstein B., Menard M., et al. Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families. Nutr J 2013, 12:145.
61. Oikonomou K.A., Orfanidou T.I., Vlychou M.K., Kapsoritakis A.N., Tsezou A., Malizos K.N., et al. Lower fibroblast growth factor 23 levels in young adults with Crohn disease as a possible secondary compensatory effect on the disturbance of bone and mineral metabolism. J Clin Densitom 2014, 17:177-184.
62. Tan B., Li P., Lv H., Li Y., Wang O., Xing X.P., et al. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease. J Dig Dis 2014, 15:116-123.
63. de Bruyn J.R., van Heeckeren R., Ponsioen C.Y., van den Brink G.R., Lowenberg M., Bredenoord A.J., et al. Vitamin D deficiency in Crohn's disease and healthy controls: a prospective case-control study in the Netherlands. J Crohns Colitis 2014, 10:1267-1273.
64. Turk N., Turk Z. Prevalent hypovitaminosis D in Crohn's disease correlates highly with mediators of osteoimmunology. Clin Invest Med 2014, 37:154-162.
65. Schoon E.J., Muller M.C., Vermeer C., Schurgers L.J., Brummer R.J., Stockbrugger R.W. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?. Gut 2001, 48:473-477.
66. Alkhouri R.H., Hashmi H., Baker R.D., Gelfond D., Baker S.S. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013, 56:89-92.
67. Jahnsen J., Falch J.A., Mowinckel P., Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002, 37:192-199.
68. Pappa H.M., Langereis E.J., Grand R.J., Gordon C.M. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011, 53:361-364.
69. Middleton J.P., Bhagavathula A.P., Gaye B., Alvarez J.A., Huang C.S., Sauer C.G., et al. Vitamin D status and bone mineral density in African American children with Crohn disease. J Pediatr Gastroenterol Nutr 2013, 57:587-593.
70. Jorgensen S.P., Hvas C.L., Agnholt J., Christensen L.A., Heickendorff L., Dahlerup J.F. Active Crohn's disease is associated with low vitamin D levels. J Crohns Colitis 2013, 7:e407-e413.
71. Lorinczy K., Lakatos P.L., Toth M., Salamon A., Nemes A., Csontos A.A., et al. Vitamin D level in Hungarian patients with inflammatory bowel diseases. Orv Hetil 2013, 154:1821-1828.
72. Sinnott B.P., Licata A.A. Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review. Endocr Pract 2006, 12:622-629.
73. Vagianos K., Bector S., McConnell J., Bernstein C.N. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2007, 31:311-319.
74. Sentongo T.A., Semaeo E.J., Stettler N., Piccoli D.A., Stallings V.A., Zemel B.S., et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 2002, 76:1077-1081.
75. Kuwabara A., Tanaka K., Tsugawa N., Nakase H., Tsuji H., Shide K., et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int 2009, 20:935-942.
76. Kelly P., Suibhne T.N., O'Morain C., O'Sullivan M. Vitamin D status and cytokine levels in patients with Crohn's disease. Int J Vitam Nutr Res 2011, 81:205-210.
77. van Hogezand R.A., Banffer D., Zwinderman A.H., McCloskey E.V., Griffioen G., Hamdy N.A. Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's disease. Osteoporos Int 2006, 17:535-542.
78. Gilman J., Shanahan F., Cashman K.D. Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr 2006, 60:889-896.
79. Farraye F.A., Nimitphong H., Stucchi A., Dendrinos K., Boulanger A.B., Vijjeswarapu A., et al. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis 2011, 17:2116-2121.
80. Atia A., Murthy R., Bailey B.A., Manning T., Garrett L.L., Youssef D., et al. Vitamin D status in veterans with inflammatory bowel disease: relationship to health care costs and services. Mil Med 2011, 176:711-714.
81. Andreassen H., Rix M., Brot C., Eskildsen P. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol 1998, 33:1087-1093.
82. Pappa H.M., Gordon C.M., Saslowsky T.M., Zholudev A., Horr B., Shih M.-C., et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006, 118:1950-1961.
83. Butcher R.O., Limdi J.K. Vitamin D status in inflammatory bowel disease: are clinicians seeing the light?. J Crohns Colitis 2012, 6:1039-1040.
84. Pappa H.M., Bern E., Kamin D., Grand R.J. Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol 2008, 24:176-183.
85. Eliades M., Spyrou E., Agrawal N., Lazo M., Brancati F.L., Potter J.J., et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013, 38:246-254.
86. Khalili H., Huang E.S., Ananthakrishnan A.N., Higuchi L., Richter J.M., Fuchs C.S., et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 2012, 61:1686-1692.
87. Leichtmann G.A., Bengoa J.M., Bolt M.J., Sitrin M.D. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr 1991, 54:548-552.
88. Wingate K.E., Jacobson K., Issenman R., Carroll M., Barker C., Israel D., et al. 25-Hydroxyvitamin D concentrations in children with Crohn's disease supplemented with either 2000 or 400 IU daily for 6 months: a randomized controlled study. J Pediatr 2014, 164:860-865.
89. Jorgensen S.P., Agnholt J., Glerup H., Lyhne S., Villadsen G.E., Hvas C.L., et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010, 32:377-383.
90. Bartels L.E., Bendix M., Hvas C.L., Jorgensen S.P., Agnholt J., Agger R., et al. Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients. Inflammopharmacology 2014, 22:95-103.
91. Yang L., Weaver V., Smith J.P., Bingaman S., Hartman T.J., Cantorna M.T. Therapeutic effect of vitamin D supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol 2013, 4:e33.
92. Luo Y.Q., Wu X.X., Ling Z.X., Cheng Y.W., Yuan L., Xiang C. Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis. J Zhejiang Univ Sci B 2014, 15:900-906.
93. Blanck S., Aberra F. Vitamin D deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci 2013, 58:1698-1702.
94. Hollis B.W. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Rheum Dis Clin North Am 2012, 38:29-44.
95. Jantchou P., Clavel-Chapelon F., Racine A., Kvaskoff M., Carbonnel F., Boutron-Ruault M.C. High residential sun exposure is associated with a low risk of incident Crohn's disease in the prospective E3 N cohort. Inflamm Bowel Dis 2014, 20:75-81.
96. Limketkai B.N., Bayless T.M., Brant S.R., Hutfless S.M. Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther 2014, 40:508-517.
97. Lim W.C., Hanauer S.B., Li Y.C. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2005, 2:308-315.
98. Beeken W.L., Busch H.J., Sylwester D.L. Intestinal protein loss in Crohn's disease. Gastroenterology 1972, 62:207-215.